Cedars Sinai Medical Center
United States of America
Education Doctorate: UCLA, 1995 Cedars-Sinai Affiliations Cancer Institute (Samuel Oschin Comprehensive Cancer Institute) Department of Biomedical Sciences Awards & Activities Co-founder and Acting Chief Scientific Officer, Eos Biosciences, 2014-present U.S. Patent No. 9,078,927, "Self-Assembling Complex For Targeting Chemical Agents To Cells", 2015 The David L. Rimoin Excellence in Teaching Award, 2013, 2014 Profiled Researcher, International Innovation Healthcare Journal, 2011, 2012 Guest Editor: Gene Therapy, 2004-05 Phi Beta Kappa, 1989-2005 National Cancer Institute CURE Award, 2003
The research of Lali Medina-Kauwe, PhD, focuses on using the cell penetration functions of pathogen proteins to develop novel cell-targeted nanotherapeutics. Medina-Kauwe is studying protein-host cell interactions, including endocytic routing, to direct the design of our nanoparticles for improved therapy. She is also currently testing these particles for cancer targeting and treatment.